Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
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
G5DvDsFJUcfHUVGb
Listen
